Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Exclusive: Prescription drug marketplace GoodRx files for IPO - sources

Published 08/02/2020, 02:23 PM
Updated 08/02/2020, 02:25 PM
© Reuters.

© Reuters.

By Joshua Franklin and Anirban Sen

(Reuters) - U.S. online prescription drug price marketplace GoodRx Inc has submitted paperwork with the U.S. Securities and Exchange Commission for a potential initial public offering, according to people familiar with the matter.

GoodRx, which was valued at $2.8 billion in 2018 when private equity firm Silver Lake invested in the company, is in the process of hiring advisers for the IPO, the sources said, requesting anonymity because the preparations are confidential.

The listing could come later this year or early in 2021, one of the sources added, noting that the plans were subject to market conditions.

GoodRx did not immediately respond to a request for comment.

Founded by Doug Hirsch and Trevor Bezdek in 2011, GoodRx gathers information for more than 70,000 U.S. pharmacies to track drug prices and offer coupons to consumers for discounts. It makes money by charging fees to partnering pharmacy benefits managers.

The Santa Monica, California-based company's website is used by more than 10 million Americans every month, according to GoodRx. Last year, it expanded into telemedicine by acquiring HeyDoctor LLC.

In June, GoodRx appointed Karsten Voermann as chief financial officer and Bansi Nagji as president for healthcare.

Besides Silver Lake, other investors in GoodRx include buyout firms Francisco Partners and Spectrum Equity. Its competitors include prescription drug savings app SingleCare and online coupon provider RetailMeNot Inc's RxSaver.

Latest comments

oh gosh. more worthless companies....I'm sure it will be bid up by the fed to 5000 times its value
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.